title: Long-term outcome of patients with AL amyloidosis treated with high-dose melphalan and stem cell transplantation: 20-year experience.
authors.affiliation: Section of Hematology-Oncology and Amyloidosis Center, Boston University School of Medicine, Boston, MA.
authors.forename: Vaishali
authors.identifier: http://orcid.org/0000-0002-6307-2445
authors.initials: V
authors.lastname: Sanchorawala
authors.affiliation: Amyloidosis Center, Boston University School of Medicine, and Department of Biostatistics, Boston University School of Public Health, Boston, MA.
authors.forename: Fangui
authors.initials: F
authors.lastname: Sun
authors.affiliation: Section of Hematology-Oncology and Amyloidosis Center, Boston University School of Medicine, Boston, MA.
authors.forename: Karen
authors.identifier: http://orcid.org/0000-0002-4243-0864
authors.initials: K
authors.lastname: Quillen
authors.affiliation: Section of Hematology-Oncology and Amyloidosis Center, Boston University School of Medicine, Boston, MA.
authors.forename: J Mark
authors.identifier: http://orcid.org/0000-0001-7069-4528
authors.initials: JM
authors.lastname: Sloan
authors.affiliation: Amyloidosis Center, Boston University School of Medicine, Boston, MA.
authors.forename: John L
authors.identifier: http://orcid.org/0000-0002-1768-2373
authors.initials: JL
authors.lastname: Berk
authors.affiliation: Section of Hematology-Oncology and Amyloidosis Center, Boston University School of Medicine, Boston, MA.
authors.forename: David C
authors.initials: DC
authors.lastname: Seldin
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000686:Amyloidosis / Q000401:mortality* / Q000628:therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage*; D008875:Middle Aged; D033581:Stem Cell Transplantation
chemical_list: D008558:Melphalan